Last $13.90 USD
Change Today -0.27 / -1.91%
Volume 722.9K
HZNP On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ronald E. Pauli

Director, Chairman of Audit Committee and Member of Compensation Committee, Horizon Pharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 4 different industries.

See Board Relationships
53$182,296

Background*

Mr. Ronald E. Pauli, also known as Ron, had been Chief Business Officer and Executive Vice President of Sagent Pharmaceuticals, Inc. since September 2011 until August 2012 and March 2012 August 2012 respectively. Mr. Pauli served as the Chief Financial Officer of Sagent Pharmaceuticals, Inc. from April 2007 to September 2011. He served as Executive Vice President, Secretary and Chief Financial Officer of NeoPharm, Inc., from August 28, 2006 to March 21, 2007. He served ...

Read Full Background

Corporate Headquarters*

520 Lake Cook Road
Deerfield, Illinois 60015

United States

Phone: 224-383-3000
Fax: 224-383-3001

Board Members Memberships*

2011-Present
Director, Chairman of Audit Committee and Member of Compensation Committee

Education*

BS
Michigan State University
Master's Degree
Walsh College Of Accountancy & Business Administration

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$65,000
Total Calculated Compensation$182,296
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HZNP:US $13.90 USD -0.27

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HORIZON PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.